Kasabach-Merritt现象诊断与治疗中国专家共识

doi:10.19438/j.cjoms.2019.02.001

中国口腔颌面外科杂志 ›› 2019, Vol. 17 ›› Issue (2): 97-105.doi: 10.19438/j.cjoms.2019.02.001

Kasabach-Merritt现象诊断与治疗中国专家共识

李克雷^1,*, 姚伟^2,*, 秦中平^1#, 李凯^2#, 郑家伟^3#, 范新东⁴, 马琳⁵, 周德凯⁶, 刘学键⁷, 尉莉⁵, 李丽⁵, 邰茂众¹, 王金湖⁸, 吉毅⁹, 周玲¹⁰, 黄海金¹¹, 高晓芸¹², 黄志见¹³, 顾松¹⁴, 杨合英¹⁵

1.山东省临沂市肿瘤医院省A级血管瘤特色专科,山东临沂 276001;
2.复旦大学附属儿科医院外科,上海 201102;
3.上海交通大学医学院附属第九人民医院·口腔医学院口腔颌面-头颈肿瘤科,上海 200011;
4.上海交通大学医学院附属第九人民医院介入科,上海 200011;
5.首都医科大学附属北京儿童医院皮肤科,北京 100045;
6.重庆医科大学附属儿童医院胃肠新生儿外科血管瘤专科,重庆 400014;
7.山东省临沂市经济技术开发区人民医院肿瘤科,山东临沂 276023;
8.浙江大学医学院附属儿童医院小儿外科,浙江杭州 310003;
9.四川大学华西医院小儿外科, 四川成都 610041;
10.新疆维吾尔自治区人民医院小儿外科,新疆乌鲁木齐 830001;
11.赣南医学院第一附属医院小儿外科,江西赣州 341000;
12.福建省立医院小儿外科,福建福州 350001;
13.苏州大学附属儿童医院小儿外科,江苏苏州 215025;
14.交通大学医学院上海市儿童医学中心小儿外科,上海 200127;
15.郑州大学第一附属医院小儿外科,河南郑州 450052

收稿日期:2019-01-08 修回日期:2019-02-10 出版日期:2019-03-20 发布日期:2019-04-12
通讯作者: 秦中平,E-mail: qinzhongping1962@163.com;李凯,E-mail: likai2727@163.com;郑家伟,E-mail: davidzhengjw@hotmail.com。^#共同通信作者
作者简介:李克雷（1971-）,男,硕士,主任医师,E-mail: likelei@sina.com;姚伟（1980-）,男,在读博士研究生,副主任医师,E-mail:2812094044@qq.com。^*并列第一作者

Chinese expert consensus on diagnosis and treatment of Kasabach-Merritt phenomenon

LI Ke-lei¹, YAO Wei², QIN Zhong-ping¹, LI Kai², ZHENG Jia-wei³, FAN Xin-dong⁴, MA Lin⁵, ZHOU De-kai⁶, LIU Xue-jian⁷, WEI Li⁵, LI Li⁵, TAI Mao-zhong¹, WANG Jin-hu⁸, JI Yi⁹, ZHOU Ling¹⁰, HUANG Hai-jin¹¹, GAO Xiao-yun¹², HUANG Zhi-jian¹³, GU Song¹⁴, YANG He-ying¹⁵

1. Special Department of Hemangioma, Tumor Hospital of Linyi City. Linyi 276001, Shandong Province;
2. Department of Pediatric Surgery, Children's Hospital of Fudan University. Shanghai 201102;
3.Department of Oral and Maxillofacial Surgery, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine. Shanghai 200011;
4. Department of Intervention Therapy, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine. Shanghai 200011;
5.Department of Dermatology, Beijing Children's Hospital affiliated to Capital Medical University. Beijing 100045;
6. Department of Infantile Hemangioma, Gastrointestinal and Neonatal Surgery, Children's Hospital of Chongqing Medical University. Chongqing 400014;
7. Department of Oncology, People's Hospital of Linyi Economic Development Zone. Linyi 276023, Shandong Province;
8. Department of Pediatric Surgery, Children's Hospital, Zhejiang University School of Medicine. Hangzhou 310003, Zhejiang Province;
9. Department of Pediatric Surgery, West China Hospital, Sichuan University. Chendu 610041, Sichuan Province;
10. Department of Pediatric Surgery, People's Hospital of Xinjiang Uygur Autonomous Region. Urumchi 830001, Xinjiang Uygur Autonomous Region;
11. Department of Pediatric Surgery, First Affiliated Hospital of Gannan Medical University. Ganzhou 341000, Jiangxi Province;
12. Department of Pediatric Surgery, Fujian Provincial Hospital. Fuzhou 350001, Fujian Province;
13. Department of Pediatric Surgery, Children's Hospital of Soochow University. Suzhou 215025, Jiangsu Province;
14. Department of Pediatric Surgery, Shanghai Children's Medical Center. Shanghai 200127;
15. Department of Pediatric Surgery, The first Affiliated Hospital of Zhengzhou University. Zhengzhou 450052, Henan Province, China

Received:2019-01-08 Revised:2019-02-10 Online:2019-03-20 Published:2019-04-12

摘要/Abstract

摘要： Kasabach-Merritt现象（卡-梅现象）是主要由卡波西样血管内皮细胞瘤或丛状血管瘤所引起的严重血小板减少和消耗性凝血功能障碍为特征的一类疾病。该类疾病好发于婴幼儿,往往起病较急,病情进展迅速,若得不到及时诊治,可引起严重并发症,甚至危及生命。鉴于当前在卡-梅现象的诊断和治疗方面还存在一定分歧,为了提高国内对卡-梅现象的认识和诊治水平,规范临床治疗,我们组织国内相关专家讨论并制定了本专家共识。该共识对卡-梅现象的发病机制、临床表现、诊断方法及治疗流程等给出了规范化建议,可供临床实践参考。

关键词: Kasabach-Merritt现象, 卡波西样血管内皮细胞瘤, 丛状血管瘤, 专家共识

Abstract: Kasabach-Merritt phenomenon (KMP) is characterized by severe thrombocytopenia and consumptive coagulation dysfunction caused by Kaposiform hemangioendothelioma or tufted angioma. KMP is predominant in infants and little children and is often with rapid progress. If KMP is not diagnosed and treated in time, it can cause serious complications and even endanger life. In view of the current controversies in the diagnosis and treatment of KMP, and in order to improve the diagnosis level and standardize treatment of KMP in China, we invited relevant experts to discuss and formulate Chinese expert consensus. The consensus provides standardized suggestions on the pathogenesis, clinical manifestations, diagnostic methods and treatment process of KMP, which can provide reference for clinical practice.

Key words: Kasabach-Merritt phenomenon, Kaposiform hemangioendothelioma, Tufted angioma, Expert consensus

中图分类号:

R739.8

李克雷, 姚伟, 秦中平, 李凯, 郑家伟, 范新东, 马琳, 周德凯, 刘学键, 尉莉, 李丽, 邰茂众, 王金湖, 吉毅, 周玲, 黄海金, 高晓芸, 黄志见, 顾松, 杨合英. Kasabach-Merritt现象诊断与治疗中国专家共识[J]. 中国口腔颌面外科杂志, 2019, 17(2): 97-105.

LI Ke-lei, YAO Wei, QIN Zhong-ping, LI Kai, ZHENG Jia-wei, FAN Xin-dong, MA Lin, ZHOU De-kai, LIU Xue-jian, WEI Li, LI Li, TAI Mao-zhong, WANG Jin-hu, JI Yi, ZHOU Ling, HUANG Hai-jin, GAO Xiao-yun, HUANG Zhi-jian, GU Song, YANG He-ying. Chinese expert consensus on diagnosis and treatment of Kasabach-Merritt phenomenon[J]. China J Oral Maxillofac Surg, 2019, 17(2): 97-105.

参考文献

[1] Kasabach HH, Merritt KK.Capillary hemangioma with extensive purpura: report of a case[J]. Arch Pediatr Adolesc Med, 1940, 59(5): 1063-1070.
[2] Zukerberg LR, Nickoloff BJ, Weiss SW.Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis[J]. Am J Surg Path,1993,17(4) : 321-328.
[3] Enjolras O, Wassef M, Mazoyer E, et al.Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas[J]. J Pediatr,1997, 130(4): 631-640.
[4] Sarkar M, Mulliken JB, Kozakewich HP, et al.Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma[J]. Plast Reconstr Surg,1997,100( 6):1377-1386.
[5] 孙玉环,车宗刚,郑家伟.ISSVA2018脉管异常新分类[J].中国口腔颌面外科杂志, 2019,17(1):7-13.
[6] Croteau SE, Liang MG, Kozakewich HP, et al.Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals[J]. J Pediatr, 2013, 162(1): 142-147.
[7] Seo SK, Suh JC, Na GY, et al.Kasabach-Merritt syndrome: identification of platelet trapping in a tufted angioma by immunohistochemistry technique using monoclonal antibody to CD61[J]. Pediatr Dermatol, 1999, 16(5): 392-394.
[8] Uhrin P, Zaujec J, Breuss JM, et al.Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation[J]. Blood,2010,115(19) : 3997-4005.
[9] Suzukiinoue K, Kato Y, Inoue O, et al.Involvement of the snake toxin receptor CLEC-2, in Podoplanin-mediated platelet activation,by cancer cells[J]. J Biol Chem,2007,282(36) : 25993-26001.
[10] O'Rafferty C, O'Regan GM, Irvine AD, et al. Recent advances in the pathobiology and management of Kasabach-Merritt phenomenon[J]. Br J Haematol,2015,171(1) :38-51.
[11] Drolet BA, Trenor CC, Brandão LR, et al.Consensus-derived practice standards plan for complicated Kaposiform hemangioendothelioma[J]. J Pediatr, 2013, 163(1): 285-291.
[12] Rodriguez V, Witman PM, Anderson PA.Kasabach-Merritt phenomenon: case series and retrospective review of the mayo clinic experience[J]. J Pediatr Hematol Oncol, 2009, 31(7): 522-526.
[13] Adams DM, Trenor CC 3rd, Hammill AM, et al. Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies[J]. Pediatrics,2016,137(2):1-10.
[14] Nadal M, Giraudeau B, Tavernier E, et al.Efficacy and safety of mammalian target of rapamycin Inhibitors in vascular anomalies: A systematic review[J]. Acta Derm Venereol, 2015,96(4): 448-452.
[15] 董倩,金先庆,高解春.小儿肿瘤外科学[M].北京:人民卫生出版社,2009:271-286.
[16] 周德凯,刘文英,刘潜.儿童血管瘤及血管畸形[C]//金先庆,施诚仁.儿童实体肿瘤诊疗指南[M].北京:人民卫生出版社,2011: 154-175.
[17] 王珊. 血管瘤及血管畸形[C]//蔡威,孙宁,魏光辉.小儿外科学[M].第5版.北京:人民卫生出版社,2014: 126-135.
[18] 任松林,齐鸿燕.儿童卡-梅现象39例回顾性分析[J]. 中华小儿外科杂志,2018,39(10): 757-761.
[19] Schmid I, Klenk AK, Sparber-Sauer M, et al.Kaposiform hemangioendothelioma in children: a benign vascular tumor with multiple treatment options[J]. World J Pediatr, 2018, 14(4):322-329.
[20] Gruman A, Liang MG, Mulliken JB, et al.Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon[J]. J Am Acad Dermatol, 2005, 52(4): 616-622.
[21] Wong BLK, Lee VNY, Tikka T, et al.Kaposiform haemangioendothelioma of the head and neck[J]. Crit Rev Oncol Hematol, 2016,104(2) :156-168.
[22] Chinello M, Di Carlo D, Olivieri F, et al.Successful management of Kaposiform hemangioendothelioma with long-term sirolimus treatment: a case report and review of the literature[J]. Mediterr J Hematol Infect Dis, 2018,10(1): e2018043.
[23] Mazoyer E, Enjolras O, Laurian C, et al.Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach-Merritt syndrome[J]. Clin Lab Haematol, 2002, 24(4): 243-251.
[24] Mulliken JB, Anupindi S, Ezekowitz RA.Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises.Case 13-2004. A newborn girl with a large cutaneous lesion, thrombocytopenia, and anemia[J]. N Engl J Med, 2004, 350(17): 1764-1775.
[25] Yao W, Li K, Wang Z, et al.Comparison of corticosteroid and vincristine in treating Kaposiform hemangioendothelioma and tufted angioma: a systematic review and meta-analysis[J]. Eur J Pediatr Surg, 2018.
[26] Kim T, Roh MR, Cho S, et al.Kasabach-merritt syndrome arising from tufted angioma successfully treated with systemic corticosteroid[J]. Ann Dermatol, 2010, 22(4): 426-430.
[27] Arunachalam P, Kumar VR, Swathi D.Kasabach-Merritt syndrome with large cutaneous vascular tumors[J]. J Indian Assoc Pediatr Surg ,2012, 17(1):33-36.
[28] Triana P, Dore M, Cerezo VN, et al.Sirolimus in the treatment of vascular anomalies[J]. Eur J Pediatr Surg, 2017, 27(1): 86-90.
[29] Huaijie W, Xinkui G, Yitao D, et al.Sirolimus as initial therapy for Kaposiform hemangioendothelioma and tufted angioma[J]. Pediatr Dermatol, 2018, 35(5): 635-638.
[30] Haisley-Royster C, Enjolras O, Frieden IJ, et al.Kasabach-merritt phenomenon: a retrospective study of treatment with vincristine[J]. J Pediatr Hematol Oncol, 2002, 24(6): 459-462.
[31] Fahrtash F, Mccahon E, Arbuckle S.Successful treatment of kaposiform hemangioendothelioma and tufted angioma with vincristine[J]. J Pediatr Hematol Oncol, 2010, 32(6): 506-510.
[32] Wang Z, Li K, Yao W, et al.Steroid-resistant kaposiform hemangioendothelioma: a retrospective study of 37 patients treated with vincristine and long-term follow-up[J]. Pediatr Blood Cancer, 2015, 62(4): 577-580.
[33] Fernandez-Pineda I, Lopez-Gutierrez JC, Chocarro G, et al.Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with Kasabach-Merritt phenomenon[J]. Pediatr Blood Cancer, 2013, 60(9): 1478-1481.
[34] Radovic SV, Kolinovic M, Ljubic D.Propranolol in the preoperative treatment of Kasabach-Merritt syndrome: a case report[J]. J Med Case Rep, 2017, 11(1): 308.
[35] Hermans DJ, van Beynum IM, van der Vijver RJ, et al. Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: a new indication for propranolol treatment[J]. J Pediatr Hematol Oncol, 2011, 33(4): e171-173.
[36] Mizutani K, Umaoka A, Tsuda K, et al.Successful combination therapy of propranolol and prednisolone for a case with congenital Kasabach-Merritt syndrome[J]. J Dermatol, 2017, 44(12): 1389-1391.
[37] Chiu YE, Drolet BA, Blei F, et al.Variable response to propranolol treatment of kaposiform hemangioendothelioma,tufted angioma,and Kasabach-Merritt phenomenon[J]. Pediatr Blood Cancer, 2012, 59(5): 934-948.
[38] Acharya S, Pillai K, Francis A, et al.Kasabach-Merritt syndrome: management with interferon[J]. Indian J Dermatol, 2010, 55(3): 281-283.
[39] Deb G, Jenkner A, De Sio L, et al.Spindle cell (Kaposiform) hemangioendothelioma with Kasabach-Merritt syndrome in an infant: successful treatment with alpha-2A interferon[J]. Med Pediatr Oncol, 1997, 28(5): 358-361.
[40] Duclaux-Loras R, Lachaux A, Guibaud L, et al.Is alfa-interferon still current in the management of Kasabach-Merritt syndrome[J]. Arch Pediatr, 2015,22(5): 523-527.
[41] O'Rafferty, O'Regan GM, Irvine AD, et al. Recent advances in the pathobiology and management of Kasabach-Merritt phenomenon[J]. Br J Haematol, 2015,171(1):38-51.
[42] Fernandez-Pineda I, Lopez-Gutierrez JC, Chocarro G, et al.Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with Kasabach-Merritt phenomenon[J]. Pediatr Blood Cancer, 2013, 60(9) : 1478-1481.
[43] Vivascolmenares GV, Ramirezvillar GL, Bernabeuwittel J, et al.The importance of early diagnosis and treatment of Kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon[J]. Dermatol Prac Concept, 2015,5(1) : 91-93.
[44] 秦中平,任莉,刘学键,等.气压法治疗小儿血管瘤[J]. 中华外科杂志, 2001,39(1): 93-94.
[45] 刘学键,邰茂众,秦中平,等.气压法治疗小儿Kasabach-Merritt现象17例分析[J]. 中华医学杂志, 2009, 89(26): 1830-1833.
[46] Li K, Tai M, Qin Z, et al.Clinical observations in mesh suture treatment for infants of Kasabach-Merritt phenomenon[J]. J Paediatr Child Health, 2015, 51(5): 529-533.
[47] Drolet BA, Scott LA, Esterly NB, et al.Early surgical intervention in a patient with Kasabach-Merritt phenomenon[J]. J Pediatr, 2001, 138(5): 756-758.
[48] Leung M, Chao NS, Tang PM, et al.Pancreatic Kaposiform hemangioendothelioma presenting with duodenal obstruction and Kasabach-Merritt phenomenon: a neonate cured by whipple operation[J]. Eur J Pediatr Surg Rep, 2014, 2(1): 7-9.
[49] Pascal S, Bettex Q, Andre N, et al.Successful surgical managment of congenital Kasabach-Merritt syndrome[J]. Pediatr Int, 2017, 59(1):89-92.
[50] 雷红召,黄静,孟小分,等.药物联合手术治疗Kasabach-Merritt综合征[J]. 中华整形外科杂志, 2013,29(2):104-108.
[51] Zou R, Peng F, Yu T, et al.Kasabach-Merritt syndrome combined with hypercalcemia: A case report[J]. Exp Ther Med, 2017, 14(6): 6164-6168.
[52] Su L, Wang D, Fan X.Comprehensive therapy for hemangioma presenting with Kasabach-Merritt syndrome in the maxillofacial region[J]. J Oral Maxillofac Surg, 2015, 73(1):92-98.
[53] 周少毅,张靖.经导管动脉硬化栓塞术治疗Kasabach-Merritt综合征[J]. 中国介入影像与治疗学, 2014, 11(7): 415-418.
[54] 谭小云,张靖,周少毅,等.经导管动脉硬化栓塞术联合长春新碱治疗激素抵抗型婴幼儿Kasabach-Merritt综合征[J]. 中华放射学杂志, 2014, 48(11):934-937.
[55] Thompson SM, Callstrom MR, McKusick MA, et al. Initial results of image-guided percutaneous ablation as second-line treatment for symptomatic vascular anomalies[J]. Cardiovasc Intervent Radiol, 2015, 38(5): 1171-1178.
[56] 葛春晓,陈涛,邰茂众,等.经皮射频消融治疗小儿Kasabach-Merritt现象初步报道[J].中国口腔颌面外科杂志,2019,17(2):175-180.
[57] Phillips WG, Marsden JR.Kasabach-Merritt syndrome exacerbated by platelet transfusion[J]. J R Soc Med, 1993, 86(4): 231-232.
[58] Korsaga-Somé N, Maruani A, Abdo I, et al.Kasabach-Merritt phenomenon (KMP) exacerbated by platelet transfusions[J]. Ann Dermatol Venereol,2015,142(10):578-580.
[59] Vivas-Colmenayes GV, Ramirez-Villar GI, Bernabeu-Wittel, et al.The importance of early diagnosis and treatment of kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon[J]. Dermatol Pract Concept, 2015, 5(1): 91-93.
[60] Enjolras O, Soupre V, Picard A.Uncommon benign infantile vascular tumors[J]. Adv Dermatol, 2008,24(2) :105-124.
[61] Schaefer BA, Wang D, Merrow AC, et al.Long-term outcome for kaposiform hemangioendothelioma: A report of two cases[J]. Pediatr Blood Cancer, 2016,64(2) : 284-286.

相关文章 15

[1]	邰茂众, 秦中平, 郑家伟, 李克雷, 刘学键, 李凯, 袁斯明, 范新东, 周德凯, 董长宪, 吉毅, 顾松, 霍然, 杨耀武, 王绪凯. 局限性血管内凝血诊断与治疗中国专家共识[J]. 中国口腔颌面外科杂志, 2024, 22(4): 313-321.
[2]	王延安, 秦中平, 郑家伟, 李春洁, 刘少华, 杨耀武, 陈刚, 陈伟良, 刘学键, 杜仲, 张雷, 王业飞, 王德明, 苏立新, 谢峰, 董长宪, 郭磊, 李凯, 顾松, 何悦, 张志愿. 头颈部血管瘤及脉管畸形手术治疗专家共识[J]. 中国口腔颌面外科杂志, 2024, 22(2): 105-117.
[3]	任振虎，陈铭韬，吴汉江，张胜，方坤，谢尚，刘宇，胡传宇，刘冰，李春洁，朱桂全，王成，高洋，张晓晨，石剑波，张永红，崔明哲，季彤，任国欣，王延安，陈伟良，张陈平，何悦，张志愿. 头颈肿瘤围术期静脉血栓栓塞症防治中国专家共识[J]. 中国口腔颌面外科杂志, 2024, 22(1): 1-9.
[4]	何悦, 陈珩, 安金刚, 郭玉兴, 潘剑, 田磊, 刘冰, 侯劲松, 李劲松, 蒋灿华, 李萌宇, 田臻, 许洁, 朱凌, 孙长伏, 郅克谦, 瞿晴, 宗春琳, 孙晶晶, 张志愿. 药物相关性颌骨坏死临床诊疗专家共识[J]. 中国口腔颌面外科杂志, 2023, 21(4): 313-325.
[5]	郑家伟, 王绪凯, 秦中平, 范新东, 李凯, 杨耀武, 霍然, 刘少华, 赵吉宏, 汪小勇, 周德凯, 刘学键. 口服普萘洛尔治疗婴幼儿血管瘤中国专家共识（2022版）[J]. 中国口腔颌面外科杂志, 2022, 20(4): 313-319.
[6]	刘冰, 何悦, 彭歆, 孙长伏, 韩正学, 吴煜农, 彭利伟, 赵熠, 陶谦, 韩新光, 李劲松, 苏彤, 李波, 张雷, 胡砚平, 陈传俊, 李一, 李铁军, 赵怡芳. 牙源性角化囊肿诊疗中国专家共识[J]. 中国口腔颌面外科杂志, 2022, 20(3): 209-218.
[7]	王育新, 王志勇, 王永功, 王慧明, 王丽珍, 田皞, 叶金海, 付坤, 阮敏, 孙长伏, 孙国文, 刘法昱, 许碧云, 后军, 刘冰, 刘亮, 陈永锋, 陈占伟, 肖灿, 李思毅, 李志勇, 李勇, 李楠, 张陈平, 张东升, 张胜, 张凯, 杨溪, 何巍, 苏彤, 季彤, 林李嵩, 罗瑞华, 赵志立, 胡勤刚, 唐瞻贵, 徐蔚嘉, 黄志权, 黄晓峰, 梁玉洁, 韩正学, 韩伟, 蒋灿华, 喻建军, 蔡志刚, 廖贵清, 廖圣恺, 蔡惠明, 魏建华. 吲哚菁绿荧光成像技术在口腔鳞癌治疗中的应用：中国专家共识[J]. 中国口腔颌面外科杂志, 2022, 20(1): 1-6.
[8]	郭伟, 任国欣, 孙沫逸, 孔蕴毅, 王丽珍, 步荣发, 冉炜, 唐瞻贵, 李龙江, 孟箭, 孙志军, 尚伟, 吕炯, 武和明, 张陈平, 何悦, 马旭辉, 宋浩, 鞠侯雨, 郑家伟, 龚忠诚, 杨凯, 张杰, 吴云腾. 中国人口腔黏膜黑色素瘤临床诊治专家共识[J]. 中国口腔颌面外科杂志, 2021, 19(6): 481-488.
[9]	陈传俊, 陈伟良, 孙长伏, 何悦, 蒋灿华, 彭歆, 尚政军, 韩正学, 李劲松, 侯劲松, 林李嵩, 韩新光, 魏建华, 王志勇, 吴煜农, 郑家伟, 李龙江, 王慧明, 李祖兵, 郭传瑸, 杨驰, 石冰, 张志愿. 颏下岛状瓣修复口腔颌面部缺损专家共识[J]. 中国口腔颌面外科杂志, 2021, 19(5): 385-391.
[10]	何悦, 蒋灿华, 侯劲松, 王慧明, 彭歆, 刘冰, 李劲松, 郑磊, 徐中飞, 吴煜农, 胡镜宙, 秦兴军, 艾松涛, 周辉红, 李春洁, 张世周, 王军, 李晓光, 刘忠龙, 祝奉硕. 穿支皮瓣修复口腔颌面-头颈部缺损专家共识[J]. 中国口腔颌面外科杂志, 2020, 18(5): 385-389.
[11]	中华口腔医学会牙及牙槽外科专业委员会. 自体牙移植术规范化操作流程中国专家共识[J]. 中国口腔颌面外科杂志, 2020, 18(5): 390-394.
[12]	鞠侯雨, 郑家伟, 孙沫逸, 唐瞻贵, 杨道科, 冉炜, 步荣发, 尚伟, 孟箭, 武和明, 席庆, 杨凯, 王军, 邹建明, 吴云腾, 任国欣, 郭伟. 口腔颌面头颈部鳞癌超声热化疗中国专家共识[J]. 中国口腔颌面外科杂志, 2020, 18(3): 193-198.
[13]	唐瞻贵, 步荣发, 郭伟, 孙沫逸, 郑家伟, 彭歆, 张惠, 段小红, 姜虹, 王淼, 张铁军, 杨旭东, 杨凯, 喻建军, 罗志勇, 谢咏秋, 胡延佳, 王柏胜. 口腔医疗中恶性高热临床诊治中国专家共识[J]. 中国口腔颌面外科杂志, 2020, 18(1): 1-9.
[14]	蒋灿华, 翦新春, 张志愿, 郑家伟, 石冰, 刘彦普, 何悦, 彭歆, 尚政军, 韩新光, 刘蔚东, 莫洋, 郭峰, 程智刚, 陈传俊, 龚忠诚, 金武龙, 张世周, 袁荣涛, 严奉国, 李鹏程, 张胜, 高兴, 陈洁. 口腔颌面外科日间手术中国专家共识[J]. 中国口腔颌面外科杂志, 2019, 17(5): 385-390.
[15]	刘建华, 张志愿, 石冰, 郭传瑸, 孙坚, 王慧明, 孙长伏, 郑谦. 唇缺损局部组织瓣修复重建专家共识[J]. 中国口腔颌面外科杂志, 2019, 17(5): 391-396.

Kasabach-Merritt现象诊断与治疗中国专家共识

Chinese expert consensus on diagnosis and treatment of Kasabach-Merritt phenomenon

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价